Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.

Gillessen S, Murphy L, James ND, Sachdeva A, El-Taji O, Abdel-Aty H, Adler AI, Amos C, Attard G, Varughese M, Gale J, Brown S, Srihari N, Birtle AJ, Brown M, Chan K, Chowdhury S, Cross W, Dearnaley DP, Din O, Dutey-Magni P, Gilbert DC, Gilson C, Gray S, Grist E, Hofmann U, Hudson AM, Jain Y, Jeyasangar G, Jones R, Kayani M, Langley RE, Malik Z, Mason MD, Matheson D, McAlpine C, Macnair A, Millman R, Murphy C, Padden-Modi M, Parikh O, Parker C, Rush H, Russell M, Srinivasan R, Sundar S, Tanguay JS, Turco F, Williams P, Sydes MR, Parmar MKB, Brown LC, Clarke NW, STAMPEDE investigators

FDA Approval Summary: Lisocabtagene Maraleucel for Relapsed or Refractory Follicular Lymphoma.

Britton K, Mahat U, Richardson NC, Tegenge M, Gao Q, Theoret MR, Fashoyin-Aje LA

State adult-use cannabis policy effects on law enforcement efforts to disrupt drug markets.

Montgomery BW, Athimuthu P, Richardson N, Ray B

A key role for parabrachial nucleus CGRP neurons in FGF1-Induced anorexia.

Scarlett JM, Hwang E, Richardson NE, Bryan CL, Redford I, Quah E, Odderson ETR, Choi PP, Hwang MK, Phan BA, Kadlec K, Alonge KM, Morton GJ, Williams KW, Schwartz MW

Molnupiravir or nirmatrelvir-ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group

Development and validation of HIV SMRTcap for the characterization of HIV-1 reservoirs across tissues and subtypes.

Sadri G, Nadakal ST, Lauer W, Kos J, Singh PK, Elliott EM, Kaiser CW, Ford EE, Richardson N, Hudson E, Linden NL, Danesh A, Powell J, Warburton P, Soto J, Emery M, Deikus G, Lee GQ, Lamers SL, Reynolds SJ, Galiwango R, Prodger JL, Tomusange S, Kityamuweesi T, Han T, Jones RB, Tobian AAR, Engelman AN, Sebra R, Morgello S, Redd AD, Sachs D, Rouchka E, Smith ML

Novel therapeutics in refractory germ cell tumors.

Richardson NH, Adra N

The spiritual needs and care of children and young people with life-threatening or life-shortening conditions, and parents (SPARK): a mixed-method investigation.

Beresford B, Richardson N, Mukherjee S, Nye R, Aldridge J, Atkin K, Clayton M, Gibson F, Hackett J, Hain R, Arshad M, Nash P, Phillips B

You Have to Make It Normal, That's What We Do": Construction Managers' Experiences of Help-Offering.

Roche E, O'Donnell S, Richardson N

The dual role of TIGIT in regulatory and effector T cells in chronic liver disease.

Bozward AG, Davies SP, Fiancette R, Wootton GE, Faustini S, Kwok HF, Richardson N, Morris SM, Kayani K, Middleton G, Oo YH

Preclinical Development of a Tolerogenic Peptide From Glutamate Decarboxylase as a Candidate for Antigen-Specific Immunotherapy in Type 1 Diabetes.

Ng STH, Price MJ, Richardson N, Nawaf M, Copland A, Streeter HB, Narendran P, Wraith DC

Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.

Leone G, Orlando F, Dutey-Magni P, Vainauskas O, Grist E, Ciani Y, Lall S, Thakali S, Wingate A, Wetterskog D, Sachdeva A, Sydes MR, McPhail N, Sreenivasan T, O'Sullivan JM, Clarke NW, Parmar MKB, Brown LC, James ND, Demichelis F, Attard G, STAMPEDE collaborators

Wildfire Smoke, the Clean Air Act, and the Exceptional Events Rule: Implications and Policy Alternatives.

Krupnick A, Richardson N, Wibbenmeyer M, Zhu Y

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group

Disproportionate Rates of COVID-19 Among Black Canadian Communities: Lessons from a Cross-Sectional Study in the First Year of the Pandemic.

Allen UD, Barton M, Upton J, Bailey A, Campigotto A, Abdulnoor M, Julien JP, Gubbay J, Kissoon N, Litosh A, La Neve MR, Wong P, Allen A, Bailey R, Byrne W, Jagoowani R, Phillips C, Merreles-Pulcini M, Polack A, Prescod C, Siddiqi A, Summers A, Thompson K, Thompson S, James C, seroMARK Research Group